1. Home
  2. RH vs ARQT Comparison

RH vs ARQT Comparison

Compare RH & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

HOLD

Current Price

$128.27

Market Cap

2.8B

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$22.75

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RH
ARQT
Founded
1979
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RH
ARQT
Price
$128.27
$22.75
Analyst Decision
Hold
Strong Buy
Analyst Count
16
7
Target Price
$233.33
$31.86
AVG Volume (30 Days)
994.6K
1.2M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
4.84
N/A
Revenue
$1,193,046,000.00
$376,072,000.00
Revenue This Year
$12.43
$34.46
Revenue Next Year
$8.92
$29.77
P/E Ratio
$27.15
N/A
Revenue Growth
24.52
91.34
52 Week Low
$123.03
$11.86
52 Week High
$264.58
$31.77

Technical Indicators

Market Signals
Indicator
RH
ARQT
Relative Strength Index (RSI) 22.14 35.75
Support Level N/A $22.56
Resistance Level $219.62 $27.26
Average True Range (ATR) 8.33 1.26
MACD -3.89 -0.26
Stochastic Oscillator 0.02 3.25

Price Performance

Historical Comparison
RH
ARQT

About RH RH

RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and is growing the presence of its hospitality business with 24 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: